Anders Persson

Anders Persson began their work experience as a Postdoctoral Fellow at Sahlgrenska University Hospital from November 2003 to January 2005. Anders then transitioned to the University of California, San Francisco, where they held roles as a Postdoctoral Fellow, Assistant Adjunct Professor, and Assistant Professor In Residence from February 2005 to July 2019. In 2019, Anders joined Celcuity as a Principal Investigator and later became a Senior Principal Investigator. In this role, they focused on identifying new combination therapies and leading research and development activities related to cancer therapeutics.

Anders Persson obtained a Master of Science (MS) degree in Biochemistry from the University of Gothenburg in 1999. Anders then pursued a Doctor of Philosophy (PhD) degree in Neurobiology from the same university, completing their studies in 2003.